How should microemulsified Cyclosporine A (Neoral®) therapy in patients with nephrotic syndrome be monitored?

被引：12

作者：

Filler, G ^{[1
]}

机构：

[1] Childrens Hosp Eastern Ontario, Div Nephrol, Dept Pediat, Ottawa, ON K1H 8L1, Canada

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷 / 06期

关键词：

Cyclosporine A; Sandimmune Neoral; nephrotic syndrome; steroid-resistant nephrotic syndrome; pharmacokinetics;

D O I：

10.1093/ndt/gfh803

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：1032 / 1034

页数：3

共 20 条

[1]

ADHIKARI M, 1994, S AFR MED J, V84, P753

[2] Increased glomerular cell heparan sulfates in vitro by ciclosporin A:: A possible explanation of its beneficial effect in idiopathic nephrotic syndrome [J].

Birmelé, B ;

De Agostini, A ;

Girardin, EP .

NEPHRON, 2001, 88 (02) :156-162

[3] Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients:: evaluation of long-term target C2 [J].

Brunet, M ;

Campistol, JM ;

Millán, O ;

Vidal, E ;

Esforzado, N ;

Rojo, I ;

Jiménez, O ;

Oppenheimer, F ;

Corbella, J ;

Martorell, J .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (07) :987-999

[4] A strategy to calculate cyclosporin A area under the time-concentration curve in pediatric renal transplantation [J].

David-Neto, E ;

Araujo, LP ;

Alves, CF ;

Sumita, N ;

Romano, P ;

Yagyu, EM ;

Nahas, WC ;

Ianhez, LE .

PEDIATRIC TRANSPLANTATION, 2002, 6 (04) :313-318

[5]

Filler G, 2002, PEDIATR TRANSPLANT, V6, P176

[6]

Filler G, 1996, LANCET, V348, P1176, DOI 10.1016/S0140-6736(05)65317-2

[7] Abbreviated cyclosporine AUCs on Neoral - the search continues! [J].

Filler, G ;

Mai, I ;

Filler, S ;

Ehrich, JHH .

PEDIATRIC NEPHROLOGY, 1999, 13 (02) :98-102

[8] Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil [J].

Gellermann, J ;

Querfeld, U .

PEDIATRIC NEPHROLOGY, 2004, 19 (01) :101-104

[9]

Gregory MJ, 1996, J AM SOC NEPHROL, V7, P543

[10] Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen [J].

Hardinger, KL ;

Schnitzler, MA ;

Koch, MJ ;

Enkvetchakul, D ;

Desai, N ;

Jendrisak, M ;

Lowell, JA ;

Miller, B ;

Shenoy, S ;

Brennan, DC .

TRANSPLANTATION, 2004, 78 (08) :1198-1203

← 1 2 →